X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (1796) 1796
ophthalmology (1671) 1671
humans (1577) 1577
bevacizumab (1506) 1506
avastin (1325) 1325
male (1006) 1006
female (995) 995
vascular endothelial growth factor a - antagonists & inhibitors (864) 864
aged (793) 793
middle aged (777) 777
antibodies, monoclonal, humanized (755) 755
macular degeneration (751) 751
endothelial growth-factor (718) 718
ranibizumab (674) 674
angiogenesis inhibitors - administration & dosage (660) 660
angiogenesis inhibitors - therapeutic use (618) 618
treatment outcome (541) 541
intravitreal injections (538) 538
vascular endothelial growth factor (466) 466
retrospective studies (456) 456
injection (444) 444
aged, 80 and over (437) 437
adult (432) 432
injections (431) 431
antibodies, monoclonal - administration & dosage (420) 420
tomography, optical coherence (420) 420
vitreous body (388) 388
fluorescein angiography (381) 381
visual acuity - physiology (361) 361
neovascularization (359) 359
bevacizumab avastin (358) 358
antibodies, monoclonal - therapeutic use (357) 357
follow-up studies (347) 347
choroidal neovascularization (346) 346
photodynamic therapy (325) 325
intravitreal bevacizumab avastin (324) 324
choroidal neovascularization - drug therapy (312) 312
intravitreal bevacizumab (303) 303
diabetic retinopathy (298) 298
therapy (289) 289
eye diseases (282) 282
prospective studies (274) 274
visual acuity (272) 272
macular degeneration - drug therapy (270) 270
angiogenesis (265) 265
animals (253) 253
angiogenesis inhibitors - adverse effects (248) 248
angiogenesis inhibitors (242) 242
antibodies, monoclonal, humanized - administration & dosage (233) 233
macular edema - drug therapy (233) 233
vegf (232) 232
age-related macular degeneration (231) 231
intravitreal injection (225) 225
macular edema (222) 222
retinopathy (211) 211
verteporfin (207) 207
care and treatment (205) 205
genetic structures (204) 204
optical coherence tomography (197) 197
antibodies, monoclonal, humanized - therapeutic use (196) 196
medicine & public health (196) 196
choroidal neovascularization - etiology (187) 187
safety (187) 187
antibodies, monoclonal - adverse effects (178) 178
secondary (178) 178
retina (177) 177
sense organs (174) 174
diabetic retinopathy - drug therapy (172) 172
triamcinolone acetonide (170) 170
pharmacology & pharmacy (165) 165
vitrectomy (164) 164
surgery (156) 156
edema (151) 151
triamcinolone (149) 149
degeneration (146) 146
visual acuity - drug effects (142) 142
research (138) 138
cancer (135) 135
abridged index medicus (133) 133
macular edema - etiology (133) 133
pharmacokinetics (132) 132
diabetic macular edema (131) 131
combined modality therapy (130) 130
physiological aspects (130) 130
anti-vegf (129) 129
choroidal neovascularization - physiopathology (129) 129
retinal vein occlusion (125) 125
drug therapy (124) 124
pegaptanib (120) 120
retina - pathology (119) 119
efficacy (117) 117
macular degeneration - complications (116) 116
diabetes (113) 113
analysis (111) 111
randomized clinical-trial (109) 109
proliferative diabetic-retinopathy (106) 106
expression (105) 105
macular degeneration - physiopathology (105) 105
photochemotherapy (104) 104
trial (104) 104
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (2174) 2174
German (81) 81
French (26) 26
Korean (16) 16
Chinese (15) 15
Spanish (14) 14
Portuguese (8) 8
Russian (6) 6
Czech (3) 3
Persian (2) 2
Hungarian (1) 1
Polish (1) 1
Slovak (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Ophthalmology, ISSN 0161-6420, 2012, Volume 119, Issue 7, pp. 1399 - 1411
Purpose To compare the efficacy and safety of ranibizumab and bevacizumab intravitreal injections to treat neovascular age-related macular degeneration (nAMD).... 
Ophthalmology | DIABETIC-RETINOPATHY | TRIAL | AVASTIN | DESIGN | OPHTHALMOLOGY | INTRAVITREAL BEVACIZUMAB | CHARTS | Macular degeneration | Chronic diseases | Angiogenesis inhibitors | Universities and colleges
Journal Article
International Heart Journal, ISSN 1349-2365, 2017
Bevacizumab, an inhibitor of vascular endothelial growth factor (VEGF) -A, is currently used to treat patients with ovarian or colon cancer. While several... 
Chemotherapy | VEGF | Avastin
Journal Article
OPHTHALMOLOGY, ISSN 0161-6420, 02/2007, Volume 114, Issue 2, pp. 400 - 401
Journal Article
International Journal of Pharmaceutics, ISSN 0378-5173, 2015, Volume 490, Issue 1-2, pp. 375 - 383
Delivery of drugs, especially bioactive macromolecules such as proteins and nucleic acids, to the posterior segment is still a significant challenge for... 
Posterior segment disorder | Thermosensitive hydrogel | Sustained release | Avastin
Journal Article
Journal of Immunological Methods, ISSN 0022-1759, 2019, Volume 469, pp. 42 - 46
The development of Bevacizumab (Avastin) biosimilar products has grown rapidly over the last ten years as the original Avastin's patent will expire soon. The... 
Sandwich ELISA PK assay | Non-VEGF competing anti-Avastin mAb | Avastin | Bevacizumab | Measurement | Medical research | Biological products | Endothelial growth factors | Monoclonal antibodies | Medicine, Experimental | Enzyme-linked immunosorbent assay
Journal Article
by Wang, J and Qi, L and Liu, L and Wang, ZJ and Chen, G and Wang, Y and Liu, XN and Liu, Y and Liu, HJ and Tong, YX and Liu, C and Lei, CP and Wang, XH
FRONTIERS IN PHARMACOLOGY, ISSN 1663-9812, 08/2019, Volume 10, pp. 905 - 905
Objective: This study compared the pharmacokinetics (PK), safety, and immunogenicity of the biosimilar TAB008 monoclonal antibody to bevacizumab (AvastiN (R))... 
BLIND | TAB008 monoclonal antibody injection | SAFETY | pharmacokinetics | PHARMACOLOGY & PHARMACY | Avastin (R) | CHINESE PATIENTS | immunogenicity | biosimilarity | Avastin
Journal Article
OPHTHALMOLOGY, ISSN 0161-6420, 05/2007, Volume 114, Issue 5, pp. 855 - 859
Purpose: To describe the pharmacokinetics of 1.25 mg of intravitreal bevacizumab (Avastin). Design: Experimental animal study. Participants: Twenty... 
REGRESSION | CLEARANCE | PROLIFERATIVE DIABETIC-RETINOPATHY | INJECTION | COHERENCE TOMOGRAPHY FINDINGS | OPHTHALMOLOGY | MACULAR DEGENERATION | RETINAL VEIN OCCLUSION | BEVACIZUMAB AVASTIN | NEOVASCULARIZATION | SHORT-TERM
Journal Article
Journal Article
OPHTHALMOLOGY, ISSN 0161-6420, 04/2007, Volume 114, Issue 4, pp. 743 - 750
Purpose: To report the 6-month anatomic and best-corrected visual acuity (BCVA) response after primary intravitreal bevacizumab (Avastin) in patients with... 
OPHTHALMOLOGY | RETINOPATHY | BEVACIZUMAB AVASTIN | INJECTION | ENDOTHELIAL GROWTH-FACTOR
Journal Article
Journal of Isfahan Medical School, ISSN 1027-7595, 08/2016, Volume 34, Issue 387, pp. 718 - 723
Journal Article
مجله دانشکده پزشکی اصفهان, ISSN 1027-7595, 08/2016, Volume 34, Issue 387, pp. 718 - 723
مقدمه: در جراحی Dacryocystorhinostomy به عنوان درمان استاندارد انسداد مجرای اشکی، عوامل مختلفی در پیش‌گیری از عود دخیل هستند. با توجه به ذکر خواص ضد فیبروز... 
Recurrence | Dacryocystorhinostomy | Avastin
Journal Article
Ophthalmology, ISSN 0161-6420, 02/2018, Volume 125, Issue 2, pp. 218 - 226
To compare structural outcome at age 4 years of eyes treated with intravitreal injection of bevacizumab with fellow eyes treated with conventional laser... 
AVASTIN | SERUM CONCENTRATIONS | THERAPY | EFFICACY | INFANTS | OPHTHALMOLOGY | ZONE-I | TIME | RANIBIZUMAB | ENDOTHELIAL GROWTH-FACTOR | Index Medicus
Journal Article
European Journal of Ophthalmology, ISSN 1120-6721, 08/2013, Volume 24, Issue 2, pp. 228 - 234
Purpose: To examine the efficacy of monthly injections of intravitreal bevacizumab (IVB) for macular edema after iodine-125 plaque radiotherapy of uveal... 
Eye | Intravitreal bevacizumab (Avastin) | Uvea | Melanoma | Tumor | Macular edema | Anti-vegf | Iodine-125 plaque radiotherapy | MACULOPATHY | AVASTIN | RADIATION RETINOPATHY | SECONDARY | ISCHEMIA | RETINAL VEIN OCCLUSION | Intravitreal bevacizumab ( Avastin) | THERAPY | PHARMACOKINETICS | INJECTION | OPHTHALMOLOGY | Anti-VEGF | ENDOTHELIAL GROWTH-FACTOR
Journal Article
Ophthalmology, ISSN 0161-6420, 07/2019, Volume 126, Issue 7, pp. 1007 - 1015
Intravitreal anti-vascular endothelial growth factor (VEGF) pharmacotherapy has become standard of care for the management of diabetic macular edema (DME). The... 
STROKE | CANCER-PATIENTS | LASER | PHOTOCOAGULATION | OPHTHALMOLOGY | RANDOMIZED-TRIAL | BEVACIZUMAB AVASTIN | AFLIBERCEPT | COMPLICATIONS | RANIBIZUMAB | ENDOTHELIAL GROWTH-FACTOR
Journal Article
The Oncologist, ISSN 1083-7159, 06/2007, Volume 12, Issue 6, pp. 713 - 718
Journal Article
Journal Article
No results were found for your search.

Cannot display more than 1000 results, please narrow the terms of your search.